Moreover, it has recently been reported that DCs are capable of inducing conversion of naive CD4+ T cells to adaptive CD4+ CD25+ Foxp3+ Treg in the presence of TGF-β or IL-10 derived from tumor cells [121]. This evidence concerns the gene TGFB1 and neoplasm.